1. Targeting Autophagy In Disease: Recent Advances In Drug Discovery
- Author
-
Ho Jeong Kwon, Hui Yun Hwang, and Dasol Kim
- Subjects
0303 health sciences ,business.industry ,Drug discovery ,Autophagy ,Cancer ,Disease ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Drug Development ,030220 oncology & carcinogenesis ,Drug Discovery ,Cancer research ,Animals ,Humans ,Medicine ,Molecular Targeted Therapy ,business ,030304 developmental biology - Abstract
Small molecules targeting autophagy have been highly implicated as new therapeutic agents to treat diseases of interest. With the increasing demand for autophagy-targeting drugs, this review attempts to provide an efficient strategy to explore major autophagy-based human disease interventions with newly explored mechanisms using small molecules and promising therapeutic approaches.Introduced in this review are direct links and applications among autophagy pathways, their modulators, and phenotypic diseases, along with recent approaches. Autophagy-related diseases, machinery, and compounds are introduced to guide the appropriate investigation of autophagy in the pharmaceutical industry. The authors then provide their expert perspectives on the subject.The self-catabolic intracellular process autophagy occurs in organisms throughout their lifetime, supporting its critical role in organismal health across life stages. Because of the detrimental influence of dysfunctional cells to an organism and their etiology in numerous diseases, maintaining cellular quality control by recycling components through autophagy is essential to prevent health decline.
- Published
- 2020
- Full Text
- View/download PDF